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Abstract 
Sphingomonas paucimobilis, is a yellow-pigmented, aerobic, non fermentative, gram negative 
motile bacillus. S. paucimobilis which is widely found in nature and hospital environments rarely 
cause serious or life threatening infections. In this report, a case of hospital acquired blood-
stream  infection  due  to  S. paucimobilis in  a  patient  with  Down  syndrome who was  on 
treatment for presumed pneumonia is presented.  
A one year-old child patient who was a known case of Down syndrome and had previously 
experienced cardiac surgery was hospitalized and treated for pneumonia. On the 12th day of 
hospitalization, blood cultures were taken because of a high body temperature. One of the 
blood  cultures  was  positive  for  gram-negative  rods.  After  48  hour  of  incubation,  the 
sub-cultures on blood agar medium yielded pure growth of a yellow, non-fermentative, 
gram-negative, rod-shaped bacterium. The microorganism was positive for oxidase, and es-
culin hydrolysis, while negative for urea and nitrate reduction, citrate utilisation and motility. 
The isolate had been identified as S. paucimobilis by using Vitek 2 system. The antibiotic 
susceptibility test was also performed with the same system and the strain was found to be 
susceptible  to piperacillin-tazobactam  and other antibiotics.  Treatment  with  intravenous 
piperacilin-tazobactam (150 mg/kg/day) was initiated. He responded well to the treatment and 
was discharged after 10 days. This case is reported to emphasize that S. paucimobilis should be 
kept in mind as a nosocomial infectious agent in patients with Down syndrome and immu-
nosuppressive patients and the infections should be treated according to the sensitivity test 
results. 
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INTRODUCTION 
S. paucimobilis is a gram-negative, slightly motile, 
non-fermentative,  oxidase  positive  opportunistic 
pathogen that rarely causes infections in humans, and 
forms yellow-pigmented S colony in blood agar (1). It 
is found in nature, notably in water and soil. It was 
first discovered as an agent in humans in 1977 and 
named  Pseudomonas paucimobilis.  It  was  renamed  as 
Sphingomonas paucimobilis in 1990 in accordance with 
phylogenetic  data  (1,2).  Varieties  of  Sphingomonas 
are widely used in biotechnology due to their ability 
for synthesis and decomposition of macromolecules 
(3). In various studies, S. paucimobilis has been shown 
to  be  a  causative  agent  of  infection  in  im-
mune-compromised patients, and in hospital acquired 
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postoperative  endophtalmitis,  septic  shock,  septic 
arthritis and osteomyelitis (1,4,5). In this report, the 
first case of S. paucimobilis identified in Turkey in a 
pediatric patient with Down syndrome is presented. 
CASE REPORT 
A  twelve-month-old  male  patient  who  was 
brought  to  the  pediatric  outpatient  clinic  in  March 
2010 with complaints of high temperature, cough and 
wheezing  was  hospitalized  with  a  presumptive  di-
agnosis of pneumonia. Since the patient had exhibited 
stigmas  of  Down  Syndrome  at  birth,  a  cytogenetic 
examination  was  conducted  and  he  was  diagnosed 
with 47 XY+21 chromosome and regular type Down 
Syndrome. The echocardiography conducted on the 
patient revealed enlargement of right heart cavities, 
Secundum Atrial Septal Defect (ASD), apical muscu-
lar  Ventricular  Septal  Defect  (VSD),  Patent  Ductus 
Arteriosis and pulmonary hypertension. After an an-
giography conducted in October 2009, it was decided 
that  surgery  be  performed  and  ASD-VSD  primary 
repair,  Patent  Foramen  Ovale  (PFO)  ligation,  and 
banding of Pulmonary artery were performed in No-
vember 2009. The patient, who  was cognitively im-
paired in terms of  neurological development stages 
and had a history of frequent infections, was hospi-
talized with the presumptive of bronchopneumonia. 
Chest x-ray of patient showed infiltration in left apex 
and by the auscultation bilateral rale and rhonchus 
were detected. Intra Venous antibiotic ceftriaxone was 
started. On the 12th day of the patient’s hospitaliza-
tion,  blood  cultures  (BACTEC,  Becton  Dickinson, 
USA) were taken. On the 2nd day of incubation, pas-
sages were performed from the bottle where growth 
was  identified  to  EMB  and  sheep  blood  agar  (bi-
oMerieux,  France).  Yellow-pigmented  smooth  colo-
nies were seen on the blood agar. In gram staining of 
these colonies, thin gram negative bacilli were identi-
fied. The microorganism was positive for motility test, 
oxidase  reaction,  citrate  reduction  and  esculin  hy-
drolysis and negative for urea and nitrate reductions. 
The isolate was identified as S.paucimobilis by using 
Vitek  2  (bioMerieux,  France)  system.  The  microor-
ganism was  identified two different times from the 
the peripheral blood and no central venous catheter. 
Investigation  of  hospital  environment  specimens 
showed no S.paucimobilis growth. There was organism 
in  the  blood  bottles  during  subculture.  Antibiotic 
susceptibility  test  was  also  performed  with  Vitek  2 
(bioMerieux, France) system and the strain was found 
to be susceptible to amikasin, gentamicin, levofloxa-
cin,  tigecycline,  trimethoprim-sulfamethoxazol  pipe-
racillin-tazobactam,  ampisilin,  amoxicilin-clavunate, 
cefuroxime,  cefuroxime-axetil,  cefepime,  imipenem, 
meropenem  and  resistant  to  ceftriaxone,  cefepime 
cephoxitin  and  cephtazidim.  A  15-day  treatment  of 
intravenous  piperacillin-tazobactam  (150 
mg/kg/day) was initiated. The fever of patient was 
disappeared. He responded well to the treatment and 
discharged. 
DISCUSSION 
S.  paucimobilis  is  a  yellow-pigmented,  aerobic, 
gram negative bacillus that is motile with polar flag-
ellation, non fermentative and is non spore forming 
(5-8).  The  bacteria  is  widely  found  in  natural  envi-
ronment, especially in water and soil (3,5,8). At the 
same time, it was isolated from respirators, hemodi-
alysis  devices,  distilled  water  containers  and  ther-
mometer props in hospital environments (3,5,8,9). S. 
paucimobilis  was  shown  to  be  an  infective  agent  in 
cases of sepsis, peritonitis, catheter-related infections, 
osteomyelitis, and endophthalmitis (9,10). 
A case of a postoperative endophthalmitis that 
was caused by Sphingomonas paucimobilis was reported 
by Seo et al in 2008 in Korea. This case demonstrates a 
delayed onset of postoperative endophthalmitis at 3 
months after cataract extraction and posterior cham-
ber  intraocular  lens  implantation  (1).  Another  case 
report was the 50-year-old male with end-stage renal 
disease who had been receiving continuous ambula-
tory peritoneal dialysis for peritonitis from  Kocaeli, 
Turkey.  It  was  an  unusual  pathogen  for  peritoneal 
dialysis (PD)-associated peritonitis (2). A rare case of 
nosocomial bacteriemia agent in bronchopneumonia 
patient who had a history hydrocephalus and expe-
rienced two ventriculoperitoneal shunt surgery was 
reported from Ankara, Turkey in 2008 (3). Reported 
another case is a patient with acute myeloid leukemia 
who developed S.paucimobilis bacteriemia complicat-
ed by septic shock just before receiving an autologous 
hematopoietic stem cell transplant at King Faisal Spe-
cialist Hospital and Research Centre in Riyadh (5). A 
nosocomial outbreak of S.paucimobilis bacteriemia in 
hemato/oncology unit was also reported in Ankara, 
Turkey in 2007. Four blood culture results were found 
positive for this microorganism (6).  
S.paucimobilis is an opportunistic pathogen (8). It 
can be pathogen in immune-suppressed patients such 
as hematology and oncology patients and in patients 
with an underlying disease. In our case, too, since the 
patient suffers from Down syndrome and underlying 
diseases, he is susceptible to infection caused by this 
microorganism (3-6,10,11). On the basis of the relevant 
literature we have reviewed, we can say that this is 
the first case of S. paucimobilis in a patient with Down 
syndrome in Turkey and probably in the world.  Int. J. Med. Sci. 2011, 8 
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There  are  cases  in  which  this  microorganism 
causes epidemics in hospitals (8). In such patients, the 
cause usually cannot be determined and are consid-
ered  to  have  endogenous  origin  (3).  However, 
S.paucimobilis  may  be  found  in  tap  water,  distilled 
water, nebulizer, respirator, dialysis liquids and other 
equipment in hospitals and lead to nosocomial infec-
tion (8). 
Among  these  species,  there  are  also  microor-
ganisms like S. mucosissima and S. adhesiva which are 
not  very  important  clinically.  However,  the  best 
known and the main pathogen within this genus is S. 
paucimobilis (5,6). S.paucimobilis is rare in comparison 
to  pseudomonas  and  other  related  species  and  has 
less pathogenic effect. This situation is accounted for 
by a lack of lipopolysaccharide in the cell wall and 
existence of glycosphingolipids instead (1,3). Antibi-
otic susceptibility of the microorganism varies from 
study to study (3,7). In our study, it was found to be 
susceptible  to  aminoglycosides,  quinolones,  trime-
toprim-sulfamethoxazoles  and  cephalosporin  apart 
from cephoxitin and cephtazidime. 
In conclusion, although S. paucimobilis is a rare 
hospital  infection,  it  should  be  kept  in  mind  as  a 
cause, by virtue of the fact that it is a part of the flora 
in  natural  environment,  especially  in  patients  with 
immunosuppressive diseases and patients who have 
other  underlying  diseases.  Since  antibiotic  suscepti-
bility  also  exhibits  variation,  patients  should  be 
treated in accordance with the antibiotic susceptibility 
results. 
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